GlobeNewswire

Arvinas to Present at Jefferies Global Healthcare Conference
11/11/2026
NEW HAVEN, Conn., Nov. 11, 2026 (GLOBE NEWSWIRE) -- Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company creating a new class of drugs based on targeted protein degradation, today announced that [...]
NRx Pharmaceuticals Begins Selling U.S.-Made, Preservative-Free Ketamine Amid Long-Running Shortage
11/11/2026
A veteran, trained, and certified 17-person sales force, commenced sales operations this week, providing national coverage with customers responsible for approximately 80% of current U.S. ketamine sales Initial supply [...]
Nurix Therapeutics Appoints Arati V. Rao, M.D., as Chief Medical Officer
11/11/2026
Physician-scientist and oncology leader brings more than two decades of experience in academic medicine, global clinical development and regulatory submissions BRISBANE, Calif., Nov. 11, 2026 (GLOBE NEWSWIRE) -- Nurix [...]
Hemab Therapeutics to Participate in Upcoming Investor Conferences
11/11/2026
CAMBRIDGE, Mass. and COPENHAGEN, Denmark, Nov. 11, 2026 (GLOBE NEWSWIRE) -- Hemab Therapeutics (Nasdaq: COAG), a clinical-stage biotechnology company developing therapies that reimagine the treatment of blood [...]
Whiskey You Won't Find on Shelves: Breckenridge Distillery Launches the 2 Mile High Whiskey Club
11/11/2026
A Fresh Way to Experience Breckenridge Distillery Through Special Bottlings, Tastings and Behind-The-Scenes Access BRECKENRIDGE, Colo., Nov. 11, 2026 (GLOBE NEWSWIRE) -- Breckenridge Distillery , one of the most awarded [...]
Sinaptica Therapeutics to Host Scientific Symposium at CTAD 2026 Exploring the Role of Brain Network Dysfunction in Alzheimer's Disease
11/11/2026
Leading Alzheimer's researchers Giacomo Koch, Emiliano Santarnecchi and Harald Hampel to examine emerging evidence, biomarkers and therapeutic approaches targeting brain network dysfunction Scientific co-founder Giacomo [...]
Nkarta Presents Initial Safety Data for NKX019 in 40 Patients Across Five Autoimmune Diseases at ACR Convergence 2026
11/11/2026
No cases of cytokine release syndrome (CRS), immune effector cell-associated neurotoxicity syndrome (ICANS), immune effector cell-associated hemophagocytic lymphohistiocytosis-like syndrome (IEC-HS), or graft-versus- [...]
CDT Commences Human Skin Studies with QIMA Life Sciences on Novel Tapinarof Combinations in Vitiligo
11/11/2026
NAPLES, Fla. and CAMBRIDGE, United Kingdom, Nov. 11, 2026 (GLOBE NEWSWIRE) -- CDT Equity Inc. (Nasdaq: CDT) (“CDT” or the “Company”) today announced that studies have commenced with QIMA Life Sciences, a world leading [...]
AC Immune to Present at Jefferies Global Healthcare Conference 2026
11/11/2026
AC Immune to Present at Jefferies Global Healthcare Conference 2026 Lausanne, Switzerland, November 11, 2026 -- AC Immune SA (NASDAQ: ACIU), a clinical-stage biopharma company targeting the key pathologic misfolded [...]
Horizon Europe-funded HERMOD project launches to support Phase 2 development of HER-096 in Parkinson’s disease
11/11/2026
Espoo, Finland, 11 November 2026: Herantis Pharma Plc (“Herantis”), a clinical-stage company developing disease-modifying therapies to stop the progression of Parkinson’s disease, today announces that the Horizon Europe [...]
CHARM Therapeutics and Collaborator Dr. Florian Perner to Present Compelling Data Showing the Potential of Next-Generation Menin Inhibitors to Deliver More Durable Responses for AML at the 8th ASH Annual Meeting
11/11/2026
LONDON – 11 November 2026 -- CHARM Therapeutics (“CHARM”, “The Company”), a clinical-stage biotechnology company addressing resistance in acute myeloid leukemia (AML) with a best-in-class menin inhibitor, today [...]
Ballipinar Dental Clinic to Bring Oral Health Advice to UK Patients During Mouth Cancer Action Month
11/11/2026
As more than 11,000 people are diagnosed with mouth cancer in the UK each year, the Antalya-based dental clinic highlights overlooked warning signs ahead of its Newcastle and Middlesbrough patient events LONDON, Nov. 11 [...]
NEXGEL Announces Noteholder Participation in Strategic Recapitalization and Approximately $1.2 Million in New Capital Funding
11/11/2026
Approximately 95% of Outstanding Convertible Note Principal Committed to Conversion, Subject to Completion of a Strategic Merger Sequence LifeScience ™ Provides $732,000, Representing 61% of Approximately $1.2 Million [...]
Beeline Medicines Announces Presentation of Phase 2 Results of Afimetoran in Systemic Lupus Erythematosus at ACR Convergence 2026
11/11/2026
– All three afimetoran doses met the primary endpoint with a placebo-adjusted difference in SRI-4 response of more than 30 percentage points at Week 48 (p<0.001 for all doses) – – Secondary endpoints were [...]
23andMe Research Institute and Scripps Research Translational Institute, a division of Scripps Research, Partner to Bring Genetics-Based Recruitment to Alzheimer's Prevention Research
11/11/2026
Partnership pairs 23andMe Research Institute's consented research community with novel Scripps Research-led Alzheimer's prevention study PALO ALTO, Calif., Nov. 11, 2026 (GLOBE NEWSWIRE) -- 23andMe Research Institute [...]
Tempest Therapeutics Exercises Option to License Senlang’s CD7-Targeted Lentiviral In Vivo CAR-T Platform Following Initial Phase 1 Results with Lead BCMA/GPRC5D Candidate
11/11/2026
-Tempest secures exclusive global rights outside China to a targeted lentiviral platform and portfolio of in vivo CAR-T candidates -Lead BCMA/GPRC5D dual-targeting in vivo CAR-T candidate evaluated in 13 patients with [...]
InnoCare Announces First Patient Dosed in Clinical Trial of Novel PSMA/ STEAP1 Bispecific ADC ICP-B381 in China
11/11/2026
BEIJING, Nov. 11, 2026 (GLOBE NEWSWIRE) -- InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company focusing on the treatment of cancer and autoimmune diseases, announced today that the first [...]
Akari Therapeutics Participates in Virtual Investor “What This Means” Segment Featuring Newly Appointed Chief Business Officer Vatnak Vat-Ho
11/11/2026
Discussion highlights Vat-Ho’s oncology business development experience, his decision to join Akari and the potential of the Company’s novel PH1 payload platform Watch the “What This Means” video here TAMPA, Fla. and [...]
FDA Meeting Could Put NeOnc's NEO100 Experimental Brain Cancer Drug on Faster Track
11/11/2026
DENVER, Nov. 11, 2026 (GLOBE NEWSWIRE) -- ( 247MarketNews ) — NeOnc Technologies Holdings (NASDAQ: NTHI) secured a Type B End-of-Phase meeting, scheduled for early January 2027, with the U.S. Food and Drug [...]

Pages

Other news

Test 2

Lorem ipsum

Test 1

Lorem upsum